Tuesday, 22 September, 2026
AI Meets Medicine: Nvidia-Backed Iambic Therapeutics Files for $100M US IPO
By TechShots Studio
San Diego-based Iambic Therapeutics has filed for a $100 million IPO on the Nasdaq under the ticker "IAM". Backed by tech giant Nvidia and the Qatar Investment Authority, the clinical-stage biotech leverages proprietary AI models and high-throughput lab automation to design small-molecule cancer therapies. Its listing highlights ongoing resilience and investor enthusiasm in the AI-driven drug discovery sector.